Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed (CL) global oral care and personal care at $20.1B revenue; world #1 toothpaste market share competing with P&G Crest and Oral-B with Hill's Prescription Diet pet nutrition as high-margin segment.
Colgate-Palmolive is a New York-based global consumer goods company manufacturing and marketing oral care (Colgate toothpaste, toothbrushes, mouthwash), personal care (Palmolive dish soap, Softsoap hand soap, Speed Stick deodorant), and pet nutrition (Hill's Science Diet, Hill's Prescription Diet) products across 200+ countries. Listed on NYSE (NYSE: CL), Colgate-Palmolive was founded in 1806 by William Colgate and generated $20.1 billion in net sales in fiscal year 2024 — holding the world's #1 toothpaste market share position globally and #1 position in over 40 countries for manual toothbrushes.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.